175 related articles for article (PubMed ID: 32057362)
1. Neuromedin U (NMU) regulates osteoblast differentiation and activity.
Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW
Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362
[TBL] [Abstract][Full Text] [Related]
2. NMUR1 in the NMU-Mediated Regulation of Bone Remodeling.
Hsiao YT; Manikowski KJ; Snyder S; Griffin N; Orr AL; Hulsey EQ; Born-Evers G; Zukosky T; Squire ME; Hum JM; Metzger CE; Allen MR; Lowery JW
Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685399
[TBL] [Abstract][Full Text] [Related]
3. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform.
Rucinski M; Ziolkowska A; Tyczewska M; Szyszka M; Malendowicz LK
Int J Mol Med; 2008 Sep; 22(3):363-8. PubMed ID: 18698496
[TBL] [Abstract][Full Text] [Related]
5. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
Lin TY; Huang WL; Lee WY; Luo CW
PLoS One; 2015; 10(8):e0136836. PubMed ID: 26317338
[TBL] [Abstract][Full Text] [Related]
6. Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic β-cells.
Zhang W; Sakoda H; Nakazato M
FASEB J; 2020 Jan; 34(1):133-147. PubMed ID: 31914613
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.
Garczyk S; Klotz N; Szczepanski S; Denecke B; Antonopoulos W; von Stillfried S; Knüchel R; Rose M; Dahl E
Oncotarget; 2017 May; 8(22):36246-36265. PubMed ID: 28423716
[TBL] [Abstract][Full Text] [Related]
8. Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2.
Lin TY; Wu FJ; Lee WY; Hsiao CL; Luo CW
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E800-9. PubMed ID: 23423171
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression patterns of neuromedin U and its receptors in pigs.
Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
[TBL] [Abstract][Full Text] [Related]
10. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
[TBL] [Abstract][Full Text] [Related]
11. Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
Przygodzka P; Sochacka E; Soboska K; Pacholczyk M; Papiewska-Pająk I; Przygodzki T; Płociński P; Ballet S; De Prins A; Boncela J
J Exp Clin Cancer Res; 2021 Sep; 40(1):283. PubMed ID: 34493299
[TBL] [Abstract][Full Text] [Related]
12. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
[TBL] [Abstract][Full Text] [Related]
13. Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine.
Li Y; Liu S; Zhou K; Wang Y; Chen Y; Hu W; Li S; Li H; Wang Y; Wang Q; He D; Xu H
Science; 2023 Sep; 381(6663):1189-1196. PubMed ID: 37708282
[TBL] [Abstract][Full Text] [Related]
14. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
15. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.
Lin SJ; Ho HC; Lee YF; Liu NC; Liu S; Li G; Shyr CR; Chang C
Reprod Biol Endocrinol; 2012 Jun; 10():43. PubMed ID: 22676849
[TBL] [Abstract][Full Text] [Related]
16. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
[TBL] [Abstract][Full Text] [Related]
17. Central control of bone remodeling by neuromedin U.
Sato S; Hanada R; Kimura A; Abe T; Matsumoto T; Iwasaki M; Inose H; Ida T; Mieda M; Takeuchi Y; Fukumoto S; Fujita T; Kato S; Kangawa K; Kojima M; Shinomiya K; Takeda S
Nat Med; 2007 Oct; 13(10):1234-40. PubMed ID: 17873881
[TBL] [Abstract][Full Text] [Related]
18. The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.
Gambone JE; Dusaban SS; Loperena R; Nakata Y; Shetzline SE
Blood; 2011 May; 117(21):5733-43. PubMed ID: 21378276
[TBL] [Abstract][Full Text] [Related]
19. Neuromedin U regulates the anti-tumor activity of CD8
Zheng R; Wang S; Wang J; Zhou M; Shi Q; Liu B
Cancer Sci; 2024 Feb; 115(2):334-346. PubMed ID: 38071753
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin.
Aizawa S; Sakata I; Nagasaka M; Higaki Y; Sakai T
PLoS One; 2013; 8(7):e67118. PubMed ID: 23843987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]